Literature DB >> 10210483

Computed tomography halo sign in pulmonary nodules: frequency and diagnostic value.

M Gaeta1, A Blandino, E Scribano, F Minutoli, S Volta, I Pandolfo.   

Abstract

On computed tomography (CT) scanning, a ground-glass opacity zone surrounding a pulmonary nodule has been named the computed tomography (CT) halo sign. To investigate the frequency and diagnostic value of the CT halo sign, the authors reviewed the CT examinations of 305 patients with proven diseases producing solitary or multiple nodules. The CT halo sign was seen in 22 patients (7%). Eleven patients had a solitary nodule; five patients had multiple nodules; and six patients had nodules associated with areas of pulmonary consolidation, or ground-glass opacity, or both. Solitary nodules were the result of bronchioloalveolar carcinoma (n = 5), tuberculoma (n = 2), squamous cell carcinoma, non-Hodgkin lymphoma, myxovirus infection, and metastasis (n = 1 each). Multiple nodules were the result of metastasis (n = 2), Kaposi sarcoma (n = 2), and Wegener granulomatosis (n = 1). Nodules associated with areas of consolidation or ground-glass opacity were the result of metastasis (n = 2), bronchioloalveolar carcinoma, bronchiolitis obliterans organizing pneumonia, eosinophilic pneumonia, and invasive pulmonary aspergillosis (n = 1 each). The data showed that the CT halo sign is a nonspecific finding. It is known that in immunocompromised patients the CT halo sign should suggest invasive pulmonary aspergillosis, Kaposi sarcoma, and lymphoproliferative pulmonary disorders. However, in immunocompetent patients, the authors found that a solitary nodule with the CT halo sign and pseudocavitations has a high likelihood of being a bronchioloalveolar carcinoma.

Entities:  

Mesh:

Year:  1999        PMID: 10210483     DOI: 10.1097/00005382-199904000-00008

Source DB:  PubMed          Journal:  J Thorac Imaging        ISSN: 0883-5993            Impact factor:   3.000


  8 in total

Review 1.  Management of an incidentally discovered pulmonary nodule.

Authors:  Catherine Beigelman-Aubry; Catherine Hill; Philippe A Grenier
Journal:  Eur Radiol       Date:  2006-10-05       Impact factor: 5.315

Review 2.  CAD (computed-aided detection) and CADx (computer aided diagnosis) systems in identifying and characterising lung nodules on chest CT: overview of research, developments and new prospects.

Authors:  F Fraioli; G Serra; R Passariello
Journal:  Radiol Med       Date:  2010-01-15       Impact factor: 3.469

Review 3.  Organizing pneumonia: a kaleidoscope of concepts and morphologies.

Authors:  Benjamin J Roberton; David M Hansell
Journal:  Eur Radiol       Date:  2011-07-10       Impact factor: 5.315

4.  Pulmonary invasive fungal disease and bacterial pneumonia: a comparative study with high-resolution CT.

Authors:  Wei Chen; Xuanqi Xiong; Bin Xie; Yuan Ou; Wenjing Hou; Mingshan Du; Yongling Chen; Kang Chen; Jing Li; Li Pei; Gang Fu; Dingyuan Liu; Ying Huang
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

Review 5.  The diagnostic value of halo and reversed halo signs for invasive mold infections in compromised hosts.

Authors:  Sarah P Georgiadou; Nikolaos V Sipsas; Edith M Marom; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

6.  Septic pulmonary embolism caused by a Klebsiella pneumoniae liver abscess: clinical characteristics, imaging findings, and clinical courses.

Authors:  Deng-Wei Chou; Shu-Ling Wu; Kuo-Mou Chung; Shu-Chen Han
Journal:  Clinics (Sao Paulo)       Date:  2015-06-01       Impact factor: 2.365

7.  Clinical manifestations and outcomes of pulmonary aspergillosis: experience from Pakistan.

Authors:  Nousheen Iqbal; Muhammad Irfan; Ali Bin Sarwar Zubairi; Kauser Jabeen; Safia Awan; Javaid A Khan
Journal:  BMJ Open Respir Res       Date:  2016-12-16

8.  The halo sign: HRCT findings in 85 patients.

Authors:  Giordano Rafael Tronco Alves; Edson Marchiori; Klaus Irion; Carlos Schuler Nin; Guilherme Watte; Alessandro Comarú Pasqualotto; Luiz Carlos Severo; Bruno Hochhegger
Journal:  J Bras Pneumol       Date:  2016 Nov-Dec       Impact factor: 2.624

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.